Marvell's Post-Earnings Drift: A Valuation Debate Masks an Otherwise Blowout Quarter

Marvell's strong Q2 results and raised outlook fail to lift shares amid dilution concerns and post-earnings profit-taking.

There is an odd disconnect playing out in Marvell Technology's stock right now. The chipmaker just delivered record revenue, raised its outlook by hundreds of millions of dollars, and guided the current quarter well ahead of Wall Street's expectations. And yet the shares keep sliding. The gap between what the company is reporting and how investors are responding says less about the business than it does about the price paid to own it.

For the second quarter of fiscal 2027, Marvell posted revenue of $2.739 billion, up 37 percent year over year, with adjusted earnings per share of $0.94. Management lifted its full-year revenue forecast by $500 million and raised the following year's outlook by $1.5 billion. Third-quarter guidance of $3.15 billion in revenue came in comfortably above the consensus estimate of $3.03 billion. By any operational measure, this was a quarter to build on.

The market has chosen to look elsewhere. Since the earnings release last Tuesday, the stock has shed 2.8 percent. Broaden the window and the picture turns uglier: shares are down 13.0 percent from roughly two weeks ago, when the CEO executed a stock sale, and 13.3 percent over a similar stretch that saw the expanded Google partnership announced. The equity last changed hands at €176.26, sitting 8.4 percent below its 50-day moving average — a sign the near-term trend has rolled over, even as the longer-term setup remains firmly constructive with the price still 33 percent above the 200-day average.

A Deal That Reads Better on Paper Than on the Tape

Part of the friction traces back to the August announcement that Marvell had broadened its collaboration with Alphabet's Google around custom silicon. The scope is strategically significant: development of AI inference accelerators, memory and networking controllers, and products tied to Google's TPU ecosystem. Few partnerships in the semiconductor world carry more weight right now.

But the structure of the agreement gave investors pause. Google received the option to acquire up to $12.2 billion worth of Marvell equity, and rather than reading that as a vote of confidence from one of the world's most demanding chip buyers, the market has fretted over potential dilution. It is a reminder that even a strategically sound deal can weigh on a stock when its mechanics invite questions.

The run-up ahead of earnings only magnified the sensitivity. Marvell shares had climbed nearly 29 percent in August before the report and had roughly tripled since the start of the year. When a stock carries that kind of momentum into a quarter, merely good results rarely suffice — the bar becomes perfection. A softer margin outlook was enough to trigger profit-taking despite the record revenue and robust growth in data center and custom silicon.

Wall Street's Verdict Is Anything but Uniform

The analyst community has responded with an unusual degree of disagreement. Craig-Hallum lifted its price target sharply from $217 to $300 while reaffirming a buy rating. Roth Capital saw enough in the quarter to initiate with a buy and a $350 target. On the more cautious end, B. Riley Financial trimmed its target from $345 to $315 but held its buy recommendation — evidence that even the bulls are recalibrating valuation. TD Cowen stayed neutral with a raised target of $245, and Cantor Fitzgerald confirmed a hold stance at $300. The spread between the lowest and highest targets, $245 to $350, captures the core tension: nobody disputes the growth, but the market cannot agree on how much of it is already in the price.

That divergence is hard to explain through fundamentals alone. The quarterly numbers have been public for days. This is a debate about perspective — whether to anchor on growth trajectory or on valuation and customer concentration.

Adding to the noise, CEO Matthew J. Murphy sold 7,500 shares in mid-August for roughly $1.77 million at a weighted average price of $236.08. The sale was executed under an automated trading plan established in December 2025, making it procedurally unremarkable. Psychologically, though, an insider sale during a period of falling prices rarely soothes nerves, even if it carries little signal about the company's prospects.

A Market Catching Its Breath

The technical picture supports the notion that this is a pause rather than a reversal. Marvell recently traded at €178.02, roughly 39 percent below its 52-week high of €290.35. Yet the stock still shows a gain of 233 percent over the past twelve months — a remarkable return that has survived the recent pullback. With 30-day volatility at 88 percent and an RSI of 43.5, the stock sits in neutral territory: neither overbought nor oversold, simply consolidating.

The fundamental drivers remain intact. Data center revenue is expanding, hyperscaler demand for custom chips shows no sign of abating, and the raised guidance points to continued momentum. The real test comes on October 6, when Marvell hosts its investor day. The question management must answer is not whether the company can grow — that much is settled — but whether it can credibly address concerns about margins and equity dilution. Until then, the stock looks set to remain volatile, caught between a business firing on all cylinders and a valuation still searching for equilibrium.

For investors, the split among analysts offers a useful framing. Those following TD Cowen or Cantor Fitzgerald will likely wait for lower entry points. Those persuaded by Craig-Hallum's thesis see the current level as a reasonable discount on an intact growth story. Both can be right — it depends entirely on the timeframe one is willing to accept.